Evaluation of the effects of curcumin capsules on prevention and prognosis of chemotherapy and radiotherapy induced oral mucositis in patients with cancer

Phase 3

• Conditions: Oral mucositis induced by chemotherapy and radiotherapy.; Oral mucositis (ulcerative) due to antineoplastic therapy; K12.31

• Registration Number: IRCT20100101002950N6
• Lead Sponsor: Rasht University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 February 2019

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients under head and neck radiotherapy
Patients under chemotherapy

Exclusion Criteria

Patients with oral lesions
Patients with systemic diseases
Smoking

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oral mucositis. Timepoint: onset of treatment, first week, second week, fourth week and seventh week. Method of measurement: Severity of erythema and ulceration by WHO and amount of pain by NRS.